We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
2.Jerling, M, Lindstroin, L, Bondesson, Uet al.Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther Drug Monit1994; 16(4): 368–74.CrossRefGoogle Scholar
3
3.Pirmohamed, M, Williams, D, Madden, Set at.Metabolism and bioactivation of clozapine by human liver in vitro. J Pharmacol Exp Ther1995 Mar; 272(3): 984–90.Google ScholarPubMed
4
4.Von, Moltke LL, Greenblatt, DJ, Cotreau-Bibbo, MMet al.Inhibitors of alprzolam metabolism in vitro: effect of serotonin-reuptake inhibitor antidepressants, ketoconazole and quinidine. Br J Clin Pharmacol1994; 36: 615–6.Google Scholar
5
5.Dahl, M, Llerena, A, Bondesson, Uet al.Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphism. Br J Clin Pharmacol1994; 37: 71–4.CrossRefGoogle Scholar
6
6.Taylor, D (Chief Pharmacist) Bethlem and Maudsley NHS Trust, Honary Lecturer, Institute of Psychiatry (personal communication).Google Scholar